Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0943-2026

1ml of DTT in liquid phase, in PET tube with capture cap, in bulk Recall

1ml of DTT in liquid phase, in PET tube with capture cap, in bulk

FDA recall Class II

Ongoing

FDA lists this Class II recall for 1ml of DTT in liquid phase, in PET tube with capture cap, in bulk. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0943-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Oct 29, 2025
FDA report date
Dec 24, 2025
Quantity in commerce
122,850 units US
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

1ml of DTT in liquid phase, in PET tube with capture cap, in bulk

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

UDI:0U020N.A - (01)18053326005043

View the original FDA recall notice

Why was this product recalled?

Treatment reagent functionality in respiratory specimens fluidification cannot be guaranteed.

What actions did Copan Italia take?

On October 29, 2025, Copan initiated a Urgent: Medical Device Recall Notification via Email to affected consignees Copan ask consignees to take the following actions: 1. Further distribution or use of the remaining product must stop immediately: trace and dispose of all affected products. 2. This notice should be passed on to all those who need to be aware within your organization. 3. Ensure that the same obligations (communication to end users and related evaluation activities) are guaranteed by any additional Customer. In particular, if you have further distributed the devices, please provide those Customers a copy of the recall notification and response form. 4. Confirm you have read and understood the recall instructions provided in the letter, in writing. If you have any questions, call Chief Operating Officer, at 030-2687211.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology